| Bioactivity | Fmoc-Gly-Gly-Phe-Gly-NH-CH2-O-CO-CH3 (compound DC-13-C) is an intermediate in the synthesis of Exatecan (HY-13631) derivatives[1]. | |||||||||
| Name | Fmoc-Gly-Gly-Phe-Gly-NH-CH2-O-CO-CH3 | |||||||||
| CAS | 2866301-96-2 | |||||||||
| Formula | C33H35N5O8 | |||||||||
| Molar Mass | 629.66 | |||||||||
| Appearance | 固体 | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Yunsheng Huang, et al. Exatecan derivatives and their applications. |
Fmoc-Gly-Gly-Phe-Gly-NH-CH2-O-CO-CH3
CAS: 2866301-96-2 F: C33H35N5O8 W: 629.66
Fmoc-Gly-Gly-Phe-Gly-NH-CH2-O-CO-CH3 (compound DC-13-C) is an intermediate in the synthesis of Exatecan (HY-13631) deriv
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.